日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414

关于在未接受过生物制剂DMARD治疗的活动性银屑病关节炎患者中应用Bimekizumab治疗的更正:来自III期随机、安慰剂对照、活性参考BE OPTIMAL研究的52周疗效和安全性结果 Ann Rheum Dis. 2023;82:1404-1414

Ritchlin, Christopher T; Coates, Laura C; McInnes, Iain B; Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Asahina, Akihiko; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Landewé, Robert B M

Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study

在 COSMOS 研究中,古塞库单抗改善了对肿瘤坏死因子抑制剂反应不足的银屑病关节炎患者的患者报告结局

Gossec, Laure; Baraliakos, Xenofon; Galloway, James; Oke, Vilija; Sfikakis, Petros; Rampakakis, Emmanouil; Sharaf, Mohamed; Lavie, Frederic; McInnes, Iain B

Sustained improvements in health status and work productivity with bimekizumab in psoriatic arthritis: 2-year results from two phase 3 studies

比美珠单抗治疗银屑病关节炎可持续改善患者的健康状况和工作效率:两项 3 期研究的 2 年结果

Tillett, William; Gossec, Laure; Husni, M Elaine; Morita, Akimichi; Ink, Barbara; Bajracharya, Rajan; Healy, Patrick; Mørup, Michael F; Walsh, Jessica A

Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies

利沙珠单抗在银屑病关节炎中 GRAPPA 各领域疗效:来自 3 期 KEEPsAKE 1 和 2 研究的汇总分析

Coates, Laura C; Blanco, Ricardo; Behrens, Frank; Ogdie, Alexis; Van den Bosch, Filip; Ranza, Roberto; Klionsky, Yael; Soliman, Ahmed M; Chen, Michael; Coombs, Derek; Shi, Linyu; Urbanik, Jamie R; Iyile, Thomas; Lippe, Ralph; Gossec, Laure

Association between rapid and sustained remission and clinician- and patient-reported outcomes in patients with rheumatoid arthritis: post hoc analysis of data from the SELECT-COMPARE study

快速缓解和持续缓解与类风湿性关节炎患者临床医生和患者报告结局之间的关联:SELECT-COMPARE 研究数据的后分析

Gossec, Laure; Patel, Jayesh; Kadakia, Aditi; Fang, Siran; Peng, Yi; Strengholt, Sander; Taylor, Peter C; Östör, Andrew

Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naïve patients in two phase 3 clinical trials

利用机器学习分析方法,结合两项 3 期临床试验中未接受过生物制剂 DMARD 治疗的患者数据,评估了 Risankizumab 对不同 PsA 表型的疗效

Gossec, Laure; Balanescu, Andra; D'Agostino, Maria Antonietta; Ogdie, Alexis; Sewerin, Philipp; Deng, Yu; Shi, Linyu; Sugimoto, Yoshiyuki; Zhong, Sheng; Xing, Yunzhao; Lippe, Ralph; Kishimoto, Mitsumasa

Subclinical psoriatic arthritis and disease interception-where are we in 2024?

亚临床银屑病关节炎和疾病阻断——到 2024 年我们处于什么阶段?

López-Medina, Clementina; McGonagle, Dennis; Gossec, Laure

How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients

患者报告结局指标如何影响银屑病关节炎治疗的强化和患者满意度?一项纳入 503 名患者的横断面研究

Coyle, Conor; Watson, Lily; Whately-Smith, Caroline; Brooke, Mel; Kiltz, Uta; Lubrano, Ennio; Queiro, Ruben; Trigos, David; Brandt-Juergens, Jan; Choy, Ernest; D'Angelo, Salvatore; Delle Sedie, Andrea; Dernis, Emmanuelle; Wirth, Théo; Guis, Sandrine; Helliwell, Philip; Ho, Pauline; Hueber, Axel; Joven, Beatriz; Koehm, Michaela; Morales, Carlos Montilla; Packham, Jon; Pinto Tasende, Jose Antonio; Ramírez, Julio; Ruyssen-Witrand, Adeline; Scrivo, Rossana; Twigg, Sarah; Welcker, Martin; Soubrier, Martin; Gossec, Laure; Coates, Laura C

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

银屑病关节炎疾病影响问卷(PsAID12)阈值在银屑病关节炎患者中的变异性:来自ReFlaP研究的数据

López-Medina, Clementina; Gorlier, Clémence; Orbai, Ana-Maria; Coates, Laura C; Kiltz, Uta; Leung, Ying-Ying; Palominos, Penelope; Cañete, Juan D; Scrivo, Rossana; Balanescu, Andra; Dernis, Emmanuelle; Meisalu, Sandra; Ruyssen-Witrand, Adeline; Soubrier, Martin; Aydin, Sibel Zehra; Eder, Lihi; Gaydukova, Inna; Lubrano, Ennio; Kalyoncu, Umut; Richette, Pascal; Husni, M Elaine; Smolen, Josef S; de Wit, Maarten; Gossec, Laure

Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS

在对TNF抑制剂反应不足的银屑病关节炎(PsA)患者中,通过综合指标评估古塞库单抗治疗1年的多领域疗效:COSMOS研究的事后分析

Gossec, Laure; Baraliakos, Xenofon; Aletaha, Daniel; Sharaf, Mohamed; Rampakakis, Emmanouil; Lavie, Frédéric; López-Medina, Clementina; Selmi, Carlo; Coates, Laura C